Get started
Author

Оксана Николаевна Шкоденко

Observed names: Oksana N Shkodenko, Oksana N. Shkodenko
ORCID: 0009-0003-3722-1237
Observed ORCID: 0009-0003-3722-1237
OpenAlex ID: A5013253952
Иммунотерапия опухолевых заболеваний
2022 · Евгений Вячеславович Щетинин, Галина Александровна Афанасьева, et al. · Экспериментальная и клиническая фармакология · 5
Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia
2019 · Vera A Gorbunova, Irina V Kolyadina, et al. · Journal of Modern Oncology · 3
The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
2019 · Irina V Kolyadina, Irina S Bulavina, et al. · Journal of Modern Oncology · 1
Comparative Efficacy of Anastrozole, Letrozole, and Fulvestrant as Endocrine Partners Combined with CDK4/6 Inhibitors in Patients with HR+/HER2– Metastatic Breast Cancer: A Real-World Evidence from the Stavropol Regional Clinical Oncology Center
2025 · Оксана Николаевна Шкоденко, Валерия Олеговна Кубышкина, et al. · Voprosy Onkologii
PDF
Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate Carcinomas
2025 · Aglaya G. Iyevleva, Svetlana N. Aleksakhina, et al. · International Journal of Molecular Sciences
PDF
Works count: 5
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type